Reeve Graham D. sold 1,792 shares of U S PHYSICAL THERAPY INC NV at $99.42 for −$178k on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
COO
COO
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$178,160.64Shares × reported price
Shares traded
1,792Common Stock
Price per share
$99.42Reported price. Read footnotes for ranges.
% of reported position traded
6.28%This security and ownership context
Holdings after
26,762Direct
Trade date
Nov 16, 2026Sell
Filed
Nov 17, 2026, 4:10 PM ET1-day reporting delay
Accession
0000885978-26-000080Code S · Transaction 403151
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 28,554 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

USPH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
USPH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −0.1%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported $99.42 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $99.16 to $99.57 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2: Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.